The FDA has said it intends to reduce or replace animal testing of some medicines, including monoclonal antibodies, with other methods that it hopes will be more relevant to human physiology. Among ...

Genetic-based technologies offer the prospect of information to guide clinical decision-making but will also have impacts on the use of health care resources. Assessing the clinical utility of genetic ...

Karius has developed a cell-free-DNA-based diagnostic test capable of identifying bacteria, mycobacteria, DNA viruses, fungi and protozoa in the blood down to the species level, thereby rapidly ...